Optiver Holding
INMB icon

Optiver Holding’s INmune Bio INMB Stock Holding History

Optiver Holding’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165 Buy
146
+4
+3% +$6 ﹤0.01% 2226
2025
Q4 		$222 Sell
142
-16
-10% -$29 ﹤0.01% 2345
2025
Q3 		$327 Buy
+158
New +$362 ﹤0.01% 2565

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Optiver Holding's INMB Position: Q1 2026 in Review

Optiver Holding increased its INmune Bio (INMB) stake by 2.8% in Q1 2026, buying an estimated $6 and bringing the position to 146 shares worth $165. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Optiver Holding first reported a position in INMB in Q3 2025 and has held it in 3 quarters since. The position peaked at $327 in Q3 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Optiver Holding held 146 shares of INmune Bio worth $165 as of Q1 2026.
  • Optiver Holding bought 4 INmune Bio shares in Q1 2026, an estimated $6.
  • INmune Bio made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2226 holding.
  • Optiver Holding first reported a position in INmune Bio in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's INmune Bio position peaked at $327 in Q3 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.